부산대학교 도서관

Gholamin S; Natri HM; Zhao Y; Xu S; Aftabizadeh M; Comin-Anduix B; Saravanakumar S; Masia C; Wong RA; Peter L; Chung MI; Mee ED; Aguilar B; Starr R; Torrejon DY; Alizadeh D; Wu X; Kalbasi A; Ribas A; Forman S; Badie B; Banovich N; Brown C

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Kim, Yeon Joo; Sheu, Katherine M; Tsoi, Jennifer; Abril-Rodriguez, Gabriel; Medina, Egmidio; Grasso, Catherine S; Torrejon, Davis Y; Champhekar, Ameya S; Litchfield, Kevin; Swanton, Charles; Speiser, Daniel E; Scumpia, Philip O; Hoffmann, Alexander; Graeber, Thomas G; Puig-Saus, Cristina; Ribas, Antoni

Journal of Clinical Investigation, vol 131, iss 12

Torrejon DY; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.; Galvez M; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.; Abril-Rodriguez G; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.; Campbell KM; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.; Medina E; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.; Vega-Crespo A; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.; Kalbasi A; Department of Radiation Oncology, UCLA, Los Angeles, California.; Comin-Anduix B; Department of Surgery, Division of Surgical Oncology, UCLA, Los Angeles, California.; Jonsson Comprehensive Cancer Center, Los Angeles, California.; Ribas A; Department of Medicine, Division of Hematology-Oncology, University of California Los Angeles (UCLA), Los Angeles, California.; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California.; Department of Surgery, Division of Surgical Oncology, UCLA, Los Angeles, California.; Jonsson Comprehensive Cancer Center, Los Angeles, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Shin, Daniel Sanghoon; Zaretsky, Jesse M; Escuin-Ordinas, Helena; Garcia-Diaz, Angel; Hu-Lieskovan, Siwen; Kalbasi, Anusha; Grasso, Catherine S; Hugo, Willy; Sandoval, Salemiz; Torrejon, Davis Y; Palaskas, Nicolaos; Rodriguez, Gabriel Abril; Parisi, Giulia; Azhdam, Ariel; Chmielowski, Bartosz; Cherry, Grace; Seja, Elizabeth; Berent-Maoz, Beata; Shintaku, I Peter; Le, Dung T; Pardoll, Drew M; Diaz, Luis A; Tumeh, Paul C; Graeber, Thomas G; Lo, Roger S; Comin-Anduix, Begoña; Ribas, Antoni

Cancer Discovery, vol 7, iss 2

Zaretsky, Jesse M; Garcia-Diaz, Angel; Shin, Daniel S; Escuin-Ordinas, Helena; Hugo, Willy; Hu-Lieskovan, Siwen; Torrejon, Davis Y; Abril-Rodriguez, Gabriel; Sandoval, Salemiz; Barthly, Lucas; Saco, Justin; Homet Moreno, Blanca; Mezzadra, Riccardo; Chmielowski, Bartosz; Ruchalski, Kathleen; Shintaku, I Peter; Sanchez, Phillip J; Puig-Saus, Cristina; Cherry, Grace; Seja, Elizabeth; Kong, Xiangju; Pang, Jia; Berent-Maoz, Beata; Comin-Anduix, Begoña; Graeber, Thomas G; Tumeh, Paul C; Schumacher, Ton NM; Lo, Roger S; Ribas, Antoni

New England Journal of Medicine, vol 375, iss 9

Abril-Rodríguez G; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Department of Molecular and Medical Pharmacology, UCLA.; Torrejon DY; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Karin D; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Department of Molecular and Medical Pharmacology, UCLA.; Campbell KM; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Medina E; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Saco JD; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Galvez M; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Champhekar AS; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Perez-Garcilazo I; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Baselga-Carretero I; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Singh J; Arcus Biosciences, Inc., Hayward, CA.; Comin-Anduix B; Department of Surgery, Division of Surgical Oncology, UCLA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.; Puig-Saus C; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA.; Ribas A; Department of Medicine, Division of Hematology-Oncology, University of California, Los Angeles (UCLA).; Department of Molecular and Medical Pharmacology, UCLA.; Department of Surgery, Division of Surgical Oncology, UCLA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA 90095, USA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA 94129, USA.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun

Grasso CS; Tsoi J; Onyshchenko M; Abril-Rodriguez G; Ross-Macdonald P; Wind-Rotolo M; Champhekar A; Medina E; Torrejon DY; Shin DS; Tran P; Kim YJ; Puig-Saus C; Campbell K; Vega-Crespo A; Quist M; Martignier C; Luke JJ; Wolchok JD; Johnson DB; Chmielowski B; Hodi FS; Bhatia S; Sharfman W; Urba WJ; Slingluff CL Jr; Diab A; Haanen JBAG; Algarra SM; Pardoll DM; Anagnostou V; Topalian SL; Velculescu VE; Speiser DE; Kalbasi A; Ribas A

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: PubMed not MEDLINE; MEDLINE

Grasso CS; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Cedars-Sinai Medical Center, Los Angeles, CA, USA. Electronic address: catherine.grasso@cshs.org.; Tsoi J; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Onyshchenko M; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Abril-Rodriguez G; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Ross-Macdonald P; Translational Bioinformatics, Bristol-Myers Squibb, Hopewell, NJ, USA.; Wind-Rotolo M; Translational Bioinformatics, Bristol-Myers Squibb, Hopewell, NJ, USA.; Champhekar A; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Medina E; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Torrejon DY; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Shin DS; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Tran P; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Kim YJ; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Puig-Saus C; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA.; Campbell K; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Vega-Crespo A; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Quist M; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Martignier C; University of Lausanne, Lausanne, Switzerland.; Luke JJ; University of Chicago, Chicago, IL, USA.; Wolchok JD; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Johnson DB; Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.; Chmielowski B; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Hodi FS; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA; Dana Farber Cancer Institute, Boston, MA, USA.; Bhatia S; University of Washington, Seattle, WA, USA.; Sharfman W; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Urba WJ; Earle A. Chiles Research Institute, Providence Cancer Institute, Portland, OR, USA.; Slingluff CL Jr; University of Virginia Health System, Charlottesville, VA, USA.; Diab A; The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Haanen JBAG; The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Algarra SM; Clínica Universitaria de Navarra, Pamplona, Spain.; Pardoll DM; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Anagnostou V; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Topalian SL; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Velculescu VE; Bloomberg-Kimmel Institute for Cancer Immunotherapy and Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA.; Speiser DE; University of Lausanne, Lausanne, Switzerland.; Kalbasi A; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA.; Ribas A; Jonsson Comprehensive Cancer Center at the University of California, Los Angeles (UCLA), Los Angeles, CA, USA; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. Electronic address: aribas@mednet.ucla.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101130617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1878-3686 (Electronic) Linking ISSN: 15356108 NLM ISO Abbreviation: Cancer Cell Subsets: MEDLINE

Torrejon DY; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Abril-Rodriguez G; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California.; Champhekar AS; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Tsoi J; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Campbell KM; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Kalbasi A; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, California.; Parisi G; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Zaretsky JM; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Garcia-Diaz A; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Puig-Saus C; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Cheung-Lau G; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, California.; Wohlwender T; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, California.; Krystofinski P; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Vega-Crespo A; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Lee CM; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Mascaro P; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Grasso CS; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Berent-Maoz B; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Comin-Anduix B; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, Los Angeles, California.; Hu-Lieskovan S; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California.; Ribas A; Division of Hematology-Oncology, Department of Medicine, University of California, Los Angeles, Los Angeles, California. aribas@mednet.ucla.edu.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, California.; Division of Surgical Oncology, Department of Surgery, University of California, Los Angeles, Los Angeles, California.; Jonsson Comprehensive Cancer Center, Los Angeles, California.; Parker Institute for Cancer Immunotherapy, San Francisco, California.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101561693 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2159-8290 (Electronic) Linking ISSN: 21598274 NLM ISO Abbreviation: Cancer Discov Subsets: MEDLINE

Abril-Rodriguez G; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA.; Torrejon DY; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Liu W; Laboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, CA, USA.; Zaretsky JM; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Nowicki TS; Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of California, Los Angeles, Los Angeles, USA.; Tsoi J; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Puig-Saus C; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Baselga-Carretero I; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Medina E; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Quist MJ; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Garcia AJ; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Senapedis W; Karyopharm Therapeutics, Newton, MA, USA.; Baloglu E; Karyopharm Therapeutics, Newton, MA, USA.; Kalbasi A; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Cheung-Lau G; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Berent-Maoz B; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Comin-Anduix B; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Hu-Lieskovan S; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Wang CY; Laboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, CA, USA.; Grasso CS; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Ribas A; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. aribas@mednet.ucla.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: PubMed not MEDLINE; MEDLINE

Abril-Rodriguez G; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA.; Torrejon DY; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Liu W; Laboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, CA, USA.; Zaretsky JM; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Nowicki TS; Department of Pediatrics, Division of Pediatric Hematology and Oncology, University of California, Los Angeles, Los Angeles, USA.; Tsoi J; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Puig-Saus C; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Baselga-Carretero I; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Medina E; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Quist MJ; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Garcia AJ; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Senapedis W; Karyopharm Therapeutics, Newton, MA, USA.; Baloglu E; Karyopharm Therapeutics, Newton, MA, USA.; Kalbasi A; Department of Radiation Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Cheung-Lau G; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Berent-Maoz B; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Comin-Anduix B; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Hu-Lieskovan S; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA.; Wang CY; Laboratory of Molecular Signaling, Division of Oral Biology and Medicine, School of Dentistry, University of California, Los Angeles, Los Angeles, CA, USA.; Department of Bioengineering, Henry Samueli School of Engineering and Applied Science, University of California, Los Angeles, Los Angeles, CA, USA.; Grasso CS; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA.; Ribas A; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Department of Molecular and Medical Pharmacology, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Department of Surgery, Division of Surgical Oncology, University of California, Los Angeles, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Jonsson Comprehensive Cancer Center, Los Angeles, CA, USA. aribas@mednet.ucla.edu.; Parker Institute for Cancer Immunotherapy, San Francisco, CA, USA. aribas@mednet.ucla.edu.

Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer

Garcia-Diaz A; Shin DS; Moreno BH; Saco J; Escuin-Ordinas H; Rodriguez GA; Zaretsky JM; Sun L; Hugo W; Wang X; Parisi G; Saus CP; Torrejon DY; Graeber TG; Comin-Anduix B; Hu-Lieskovan S; Damoiseaux R; Lo RS; Ribas A

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: PubMed not MEDLINE; MEDLINE

Garcia-Diaz A; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA. Electronic address: agdiaz@ipb.csic.es.; Shin DS; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.; Moreno BH; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA; Division of Translational Oncology, Carlos III Health Institute, 28029 Madrid, Spain.; Saco J; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.; Escuin-Ordinas H; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.; Rodriguez GA; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.; Zaretsky JM; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.; Sun L; Division of Dermatology, Department of Medicine, UCLA, Los Angeles, CA 90095, USA.; Hugo W; Division of Dermatology, Department of Medicine, UCLA, Los Angeles, CA 90095, USA.; Wang X; Statistics Core, Department of Medicine, UCLA, Los Angeles, CA 90095, USA.; Parisi G; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.; Saus CP; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.; Torrejon DY; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.; Graeber TG; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; Crump Institute for Molecular Imaging, UCLA, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA.; Comin-Anduix B; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA; Division of Surgical Oncology, Department of Surgery, UCLA, Los Angeles, CA 90095, USA.; Hu-Lieskovan S; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.; Damoiseaux R; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; California NanoSystems Institute, UCLA, Los Angeles, CA 90095, USA.; Lo RS; Division of Dermatology, Department of Medicine, UCLA, Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA.; Ribas A; Division of Hematology-Oncology, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA; Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, CA 90095, USA; Jonsson Comprehensive Cancer Center, UCLA, Los Angeles, CA 90095, USA; Division of Surgical Oncology, Department of Surgery, UCLA, Los Angeles, CA 90095, USA. Electronic address: aribas@mednet.ucla.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 101573691 Publication Model: Print Cited Medium: Internet ISSN: 2211-1247 (Electronic) NLM ISO Abbreviation: Cell Rep Subsets: MEDLINE